Wall Street RegretsThe regret calculator.

What if you'd held MYGN?

A $1,000 investment in Myriad Genetics, Inc. (MYGN) at the month-end close of 1995-10 would be worth $521 at the close of 2026-08 — -47.9% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $13,255.

$1,000 since 1995$521Total return-47.9%Multiple0.52×CAGR-2.1%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$521Gain+$-479 (-47.9%)Multiple0.5×CAGR-2.1%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2000$3062001$85.022002$1342003$4822004$5472005$3122006$3382007$2252008$1522009$1062010$1222011$1402012$1522013$1172014$1522015$93.662016$73.912017$1912018$92.872019$1102020$1172021$1612022$1162023$2202024$1672025$2332026$519

    Every year, $1,000 from 1995

    YearValue of $1,000Year return
    1995$1,000
    1996$773-22.7%
    1997$743-3.8%
    1998$307-58.7%
    1999$1,409+359.5%
    2000$5,070+259.7%
    2001$3,226-36.4%
    2002$895-72.3%
    2003$788-11.9%
    2004$1,380+75.1%
    2005$1,274-7.6%
    2006$1,918+50.5%
    2007$2,845+48.3%
    2008$4,059+42.7%
    2009$3,526-13.1%
    2010$3,086-12.5%
    2011$2,830-8.3%
    2012$3,682+30.1%
    2013$2,835-23.0%
    2014$4,603+62.3%
    2015$5,832+26.7%
    2016$2,253-61.4%
    2017$4,642+106.1%
    2018$3,928-15.4%
    2019$3,680-6.3%
    2020$2,672-27.4%
    2021$3,730+39.6%
    2022$1,961-47.4%
    2023$2,586+31.9%
    2024$1,853-28.4%
    2025$831-55.1%
    2026$431-48.1%

    Best and worst month-end to buy

    The best single month-end close to have bought MYGN was 1998-08 ($1.70): $1,000 then is $1,876 today. The worst was 2000-10 ($54.41): $1,000 then is $58.63.

    FAQ

    What would $1,000 in MYGN be worth today?

    A $1,000 investment in Myriad Genetics, Inc. (MYGN) at the start of 1995 would be worth about $521 today, a total return of -47.9%. Dividends are reinvested in these figures.

    What were the best and worst years for MYGN?

    Myriad Genetics, Inc. (MYGN)'s strongest calendar year since 1995 was 1999, a +359.5% return — $1,000 held through that year became about $4,595 by year-end. Its weakest year was 2002, at -72.3%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in MYGN have grown?

    Investing $100 at the end of every month since 1995-10 would have grown to about $10,799 on $37,100 invested.

    Did MYGN beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $13,255. MYGN trailed the S&P 500 by +96.1% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Myriad Genetics, Inc. (MYGN) historical total-return data from 1995-10 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.